E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/31/2014 in the Prospect News PIPE Daily.

DanDrit Biotech USA settles $2 million private placement of its stock

Company sells 400,000 common shares at $5.00 per share in offering

By Devika Patel

Knoxville, Tenn., Dec. 31 – DanDrit Biotech USA, Inc. completed a $2 million private placement of stock on Dec. 31, according to an 8-K filed Wednesday with the Securities and Exchange Commission.

The company sold 400,000 common shares at $5.00 apiece.

The private biotechnology company is based in Copenhagen.

Issuer:DanDrit Biotech USA, Inc.
Issue:Common stock
Amount:$2 million
Shares:400,000
Price:$5.00
Warrants:No
Settlement date:Dec. 31

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.